| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.8% | 1.9% |
| Div Cover | 4.3 | 4.3 |
| Op Mrgn | 20.2% | 23.1% |
| ROCE | 41.0% |
| Latest | F'cast | |
|---|---|---|
| P/E | 12.7 | 12.5 |
| PEG | 10.4 | 4.9 |
| Pr/Revenue | 2.0 | 2.0 |
| Pr/Book | 2.7 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 7.8% | -60.0% |
| PBT | -5.3% | -53.5% |
| EPS | 1.2% | 2.6% |
| DPS | 10.0% | -59.2% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 3,369.00 | 469.00 | 52.00¢ | 17.5 | 0.7 | +24% | 11.89¢ | 1.3% |
| 31-Dec-08 | 3,801.00 | 564.00 | 55.60¢ | 12.3 | 1.8 | +7% | 13.08¢ | 1.9% |
| 31-Dec-09 | 3,772.00 | 670.00 | 65.60¢ | 15.3 | 0.8 | +18% | 14.39¢ | 1.4% |
| 31-Dec-10 | 3,962.00 | 895.00 | 73.60¢ | 14.4 | 1.2 | +12% | 15.82¢ | 1.5% |
| 31-Dec-11 | 4,270.00 | 848.00 | 74.50¢ | 13.1 | 13.1 | +1% | 17.40¢ | 1.8% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 2,673.14 | 617.86 | 48.35p | 12.5 | 4.9 | +3% | 11.12p | 1.9% |
| 31-Dec-13 | 2,752.54 | 636.67 | 50.90p | 11.9 | 2.2 | +5% | 11.89p | 2.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 15-May-2012 | 15:41 | RNS |
| Director/PDMR Shareholding | 08-May-2012 | 17:06 | RNS |
| Smith & Nephew completes biologics venture | 08-May-2012 | 07:00 | RNS |
| S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
| Under siege hip-maker Smith & Nephew loses its b... | 11-Feb-2011 | Daily Mail |
| Illingworth quits Smith & Nephew | 11-Feb-2011 | The Scotsman |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 605.50p |
| Change Today | 5.50p |
| % Change | 0.92 % |
| 52 Week High | 686.50p |
| 52 Week Low | 521.00p |
| Volume | 3,114,218 |
| Shares Issued | 896.36m |
| Market Cap | £5,428m |
| Beta | 0.69 |
| RiskGrade | 93 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 10 |
| Buy | 1 |
| Neutral | 16 |
| Sell | 0 |
| Strong Sell | 2 |
| Total | 29 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 18-Apr-12 | 12-Oct-11 |
| Paid | 09-May-12 | 01-Nov-11 |
| Amount | 10.80¢ | 6.60¢ |
| Time | Volume / Share Price |
| 17:02 | 939,503 @ 605.91p |
| 17:01 | 4,300 @ 605.91p |
| 16:52 | 42,100 @ 605.91p |
| 16:46 | 2,997 @ 604.75p |
| 16:46 | 6,654 @ 605.24p |
| Chair | John Buchanan |
| CFO | Adrian Nevil Hennah |
You are here: research